Sildenafil Tablet, Film Coated
Product Images NDC 0093-5343

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 0093-5343). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of sildenafil active ingredient. The diagram shows the molecular formula representation with connected atoms and functional groups consistent with sildenafil's chemical composition.*

FDA Label Image

Sildenafil Tablets Usp 50 mg, 30s Label (Image 10)

Label for Sildenafil Tablets USP 50 mg by Teva Pharmaceuticals USA, Inc. The film-coated tablets are supplied in a package of 30 tablets. The label includes dosage instructions, storage conditions, and warnings, with the NDC number 0093-5342-56 clearly displayed.*

FDA Label Image

Sildenafil Tablets Usp 100 mg, 30s Label (Image 11)

Sildenafil Tablets USP 100 mg film-coated tablets label with NDC 0093-5343-56, manufactured by Teva Pharmaceuticals USA, Inc. The label includes prescription-only designation, package size of 30 tablets, storage instructions, child-resistant closure note, and manufacturer details from Croatia.*

FDA Label Image

Image 2

A line graph showing systolic blood pressure changes (mmHg) over 24 hours post-dose. The x-axis represents time in hours, and the y-axis shows systolic blood pressure changes. Two lines compare Sildenafil 100 mg and placebo effects, with data points marked for each treatment group.*

FDA Label Image

Image 3

A line graph showing the change in systolic blood pressure (SBP) in mm Hg over time postdose (hours) for two treatments: Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg. The x-axis represents time in hours from 0 to 8, and the y-axis represents the change in SBP ranging from -40 to 20 mm Hg. The graph compares the blood pressure changes over 8 hours postdose between the two groups.*

FDA Label Image

Image 4

A line graph depicting the change in systolic blood pressure (SBP) over time postdose in hours. Two data series are shown: one for Doxazosin plus Placebo and another for Doxazosin plus Sildenafil 50 mg, comparing their effects on SBP changes over an 8-hour period.*

FDA Label Image

Image 5

A line graph showing the change in mmHg over time after dosing (hours) for two treatments: Doxazosin combined with Sildenafil 100 mg and Doxazosin combined with Placebo. The graph tracks blood pressure measurements at various intervals up to 8 hours post-dose.*

FDA Label Image

Image 6

A line graph depicting plasma concentrations (ng/mL) of Sildenafil over time post dose (hours). The x-axis represents time from 0 to 24 hours, and the y-axis shows plasma concentration levels from 0 to 500 ng/mL. Data points are marked for a commercial tablet, showing a peak plasma concentration around 1 hour followed by a gradual decline over 24 hours.*

FDA Label Image

Image 7

Two bar charts depicting the effect of Sildenafil Citrate and placebo on maintenance of erection by baseline score. Each chart shows the percentage of patients at endpoint across baseline scores 0 to 5, with bars representing different categories labeled 0 through 5 in the legend. The top chart is for Sildenafil Citrate and the bottom for placebo.*

FDA Label Image

Image 8

A bar graph showing the percentage of patients reporting improvement in four treatment groups: placebo (24%), Sildenafil 25 mg (63%), Sildenafil 50 mg (74%), and Sildenafil 100 mg (82%). The graph compares patient-reported improvement across these groups in a clinical study.*

FDA Label Image

Image 9

Sildenafil Tablets USP 25 mg film-coated tablet label from Teva Pharmaceuticals USA, Inc. The label states the quantity as 30 tablets, includes the NDC number 0093-5341-56, and notes that the product is prescription-only. Storage instructions specify 20 to 25°C controlled room temperature, protected from light and moisture.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.